Diabetes Strategies for Primary Care-Managing T2DM in CKD

Video Transcription

Video Summary

In this video, Dr. Rodolfo Galindo discusses the management of type 2 diabetes in patients with advanced chronic kidney disease (CKD) and the challenges of glycemic monitoring and management in this population. He explains that glycemic control is important in preventing complications and mortality in patients with CKD, and highlights the need for personalized assessment of glycemic control markers in this population. Dr. Galindo mentions the limitations of using hemoglobin A1c (A1c) as a marker of glycemic control in CKD patients and suggests considering alternative markers such as glycated albumin or fructosamine. He also discusses the use of continuous glucose monitoring (CGM) in this population and emphasizes the importance of avoiding over-insulinization in CKD patients to minimize the risk of hypoglycemia. Dr. Galindo suggests using lower doses of insulin or considering non-insulin agents like DPP4 inhibitors or GLP-1 analogs in CKD patients. Finally, he highlights the need for further research and clinical studies to determine the best approaches for managing diabetes in patients with advanced CKD.

Keywords

type 2 diabetes

advanced chronic kidney disease

glycemic monitoring

glycemic management

complications

glycemic control markers

hemoglobin A1c

continuous glucose monitoring

hypoglycemia

DPP4 inhibitors